Your browser doesn't support javascript.
loading
Comparison of the PRNT and an immune fluorescence assay in yellow fever vaccinees receiving immunosuppressive medication.
Wieten, Rosanne W; Jonker, Emile F F; Pieren, Daan K J; Hodiamont, Caspar J; van Thiel, Pieter P A M; van Gorp, Eric C M; de Visser, Adriëtte W; Grobusch, Martin P; Visser, Leo G; Goorhuis, Abraham.
Afiliación
  • Wieten RW; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: a.goorhuis@amc.uva.nl.
  • Jonker EF; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Pieren DK; Department for Immune Mechanisms (IMM), Centre for Immunology od Infectious Diseases and Vaccines (IIV), National Institute for Public Health and the Environment (RIVM), Utrecht, The Netherlands.
  • Hodiamont CJ; Department of Virology, Academic Medical Center, Amsterdam, The Netherlands.
  • van Thiel PP; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • van Gorp EC; Department of Viroscience, Erasmus Medical Center, Rotterdam, The Netherlands.
  • de Visser AW; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Grobusch MP; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Visser LG; Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Goorhuis A; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Vaccine ; 34(10): 1247-51, 2016 Mar 04.
Article en En | MEDLINE | ID: mdl-26845742
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_transmissiveis / 2_enfermedades_transmissibles Asunto principal: Pruebas de Neutralización / Huésped Inmunocomprometido / Técnica del Anticuerpo Fluorescente Directa / Vacuna contra la Fiebre Amarilla / Inmunosupresores Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Vaccine Año: 2016 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_transmissiveis / 2_enfermedades_transmissibles Asunto principal: Pruebas de Neutralización / Huésped Inmunocomprometido / Técnica del Anticuerpo Fluorescente Directa / Vacuna contra la Fiebre Amarilla / Inmunosupresores Tipo de estudio: Observational_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Vaccine Año: 2016 Tipo del documento: Article